The 21 European Biotech Companies to Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
11/01/2021 - 11 minutes
Genmab
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
11/06/2020 - 3 minutes
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis…
17/09/2019 - 4 minutes
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
18/07/2019 - 2 minutes
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could…
11/06/2019 - 2 minutes
The 8 Best Biotech Companies in Europe’s History
We’ve put together a list of the best biotech companies in Europe to celebrate their…
02/04/2019 - 8 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results
An antibody therapy for the blood cancer multiple myeloma achieved positive results at Phase III,…
31/10/2018 - 2 minutes
The Billion-Euro European Biotech Companies in 2018
Here’s the list of the European biotech companies, both public and private, that are worth…
29/10/2018 - 7 minutes
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was…
23/01/2018 - 10 minutes
Novartis Takes Genmab’s Leukemia Drug Off the Market
Genmab's leukemia drug will be available around the world through compassionate use programs, while it will…
22/01/2018 - 3 minutes
